|
|
Volumn 9, Issue 11, 1998, Pages 1151-1154
|
|
Primary chemotherapy: A better overall therapeutic option for patients with breast cancer: Editorial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
GROWTH FACTOR;
METHOTREXATE;
MITOMYCIN;
MITOXANTRONE;
NAVELBINE;
PACLITAXEL;
TAMOXIFEN;
ADJUVANT CHEMOTHERAPY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
EDITORIAL;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
META ANALYSIS;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
HUMANS;
|
|
EID: 0031743933
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008427218935 Document Type: Editorial |
|
Times cited : (8)
|
|
References (38)
|
